ROBERT KING, M.D.
Marriage and Family Therapists at 56 St, Oklahoma City, OK
License number
Oklahoma 26520
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
3500 NW 56Th St STE 100, Oklahoma City, OK 73112
Phone
(405) 951-2855
Professional information
Dr. Robert King, Talihina OK - MD (Doctor of Medicine)
Specialties:
Family Medicine, Ophthalmology
Address:
205 Dallas St, Talihina 74571
(918) 567-3636 (Phone), (918) 567-3635 (Fax)
3500 NW 56Th St STE 100, Oklahoma City 73112
(405) 951-2855 (Phone)
(918) 567-3636 (Phone), (918) 567-3635 (Fax)
3500 NW 56Th St STE 100, Oklahoma City 73112
(405) 951-2855 (Phone)
Certifications:
Family Practice, 2011, Ophthalmology, 1956
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Oklahoma / Health Sciences Center
Graduated: 2008
St Anthony Hospital
Cleveland Clinic
University of Oklahoma / Health Sciences Center
Graduated: 2008
St Anthony Hospital
Cleveland Clinic
Robert Wallace King, Oklahoma City OK
Specialties:
Ophthalmology, Family Medicine
Work:
Great Plains Family Medicine Residency Program
3500 NW 56Th St, Oklahoma City, OK 73112
3500 NW 56Th St, Oklahoma City, OK 73112
Education:
University of Oklahoma(2008)
Robert King - Oklahoma City, OK
Work:
Locke supply
Assistant manager
Assistant manager
Education:
Edmond Santa fe - Edmond, OK
High school diploma in Basic studies
High school diploma in Basic studies
Method Of Human Prohibitin Gene Analysis
US Patent:
5776738, Jul 7, 1998
Filed:
Oct 8, 1996
Appl. No.:
8/728259
Inventors:
Robert Thomas Dell'Orco - Edmond OK
J. Keith MClung - Norman OK
Eldon Jupe - Norman OK
Robert King - Oklahoma City OK
J. Keith MClung - Norman OK
Eldon Jupe - Norman OK
Robert King - Oklahoma City OK
Assignee:
Oklahoma Medical Research Foundation - Oklahoma City OK
International Classification:
C12P 1934, C12Q 168
US Classification:
435 912
Abstract:
The 3' untranslated region of the human prohibitin gene has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for the treatment of cancer.
3' Untranslated Region Of The Human Prohibitin Gene
US Patent:
5922852, Jul 13, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/473486
Inventors:
Robert Thomas Dell'Orco - Edmond OK
J. Keith MClung - Norman OK
Eldon Jupe - Norman OK
Robert King - Oklahoma City OK
J. Keith MClung - Norman OK
Eldon Jupe - Norman OK
Robert King - Oklahoma City OK
Assignee:
Oklahoma Medical Research Foundation - Oklahoma City OK
International Classification:
C07H 2104, C12N 1500
US Classification:
536 231
Abstract:
The 3' untranslated region of the human prohibitin gene has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for the treatment of cancer.